January 21, 2009 – Takeda Pharmaceutical Company Limited announced today that a New Drug Application for ECARD, a fixed dose combination tablet of Blopress (generic name: candesartan cilexetil) and a low-dose diuretic (generic name: hydrochlorothiazide) for treatment of hypertension, was approved on January 21 by the Japanese Ministry of Health, Labour and Welfare.
The details can be read here.
No comments:
Post a Comment